Lannett Company Inc. 2023-01-25 Health moderate FDA
Health · FDA · Recall #FDA-D-0161-2023
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000… Recall
Issued January 25, 2023 · Lannett Company Inc.
In January 2023, Lannett Company Inc. recalled the Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurity/Degradation Specifications
What you should do
- 1 Stop using Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Lannett Company Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Lannett Company Inc.
- Category
- Health
- Recall date
- January 25, 2023
- Units affected
- Not reported
- Sold at
- Nationwide USA
- Recall number
- FDA-D-0161-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Lannett Company Inc. has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.